ArticleBMC health services research2026
Time analysis of hospital costs for respiratory diseases in Brazil, 1998-2021.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRespiratory diseases (RD) affect individuals of all age groups, negatively impacting patients' quality of life and incurring significant costs to healthcare services. If not managed properly, they can also lead to mortality. Information provided by DATASUS on RD can be utilized to facilitate professional decision-making, set targets for approach and treatment, and support the creation of public policies aimed at this population.
objectiveTo assess the financial costs of hospital admissions in the Brazilian population caused by respiratory diseases from 1998 to 2021.
methodsThis is a retrospective, population-based, ecological time-series study using secondary administrative hospital data in the Hospital Information System of the Unified Health System (SIH/SUS), regarding the costs generated by respiratory diseases in Brazil, including individuals aged 0 to 80 years. The data were analyzed using GraphPad Prism software version 8.0, and the significance level was set at 5%.
resultsA total of 34,749,023 hospitalizations due to respiratory diseases were recorded in Brazil, resulting in an accumulated expenditure of R$23.65 billion and an average cost of R$760.62 per hospitalization. Adults aged 20 to 80 years accounted for the highest number of admissions and total costs. Among respiratory conditions, pneumonia represented the greatest financial burden to the public health system across all age groups. Regionally, the South region showed the highest population-adjusted hospital costs, while men presented higher in-hospital mortality rates, and the Southeast region exhibited the longest average length of hospital stay, particularly among older adults.
conclusionRespiratory diseases, in addition to representing a public health problem, impose a significant financial burden on the Brazilian Unified Health System (SUS). It is essential to prioritize strategic planning and targeted actions to address these conditions, particularly pneumonia, considering the higher population-adjusted costs in the South, greater in-hospital mortality among men, and the longer hospital length of stay in the Southeast, aiming to reduce public health inequalities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.